XSWXDESN
Market cap3.35bUSD
Dec 20, Last price
216.50CHF
1D
-0.92%
1Q
-17.37%
Jan 2017
403.78%
IPO
893.12%
Name
Dottikon Es Holding AG
Chart & Performance
Profile
Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also provides Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities; and provision of consulting services for investment companies, and software and engineering services. Dottikon Es Holding AG was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon Es Holding AG is a subsidiary of EVOLMA Holding AG.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 326,270 2.13% | 319,452 26.80% | 251,933 15.09% | |||||||
Cost of revenue | 243,450 | 216,600 | 180,660 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 82,820 | 102,852 | 71,273 | |||||||
NOPBT Margin | 25.38% | 32.20% | 28.29% | |||||||
Operating Taxes | 11,845 | 6,501 | 10,430 | |||||||
Tax Rate | 14.30% | 6.32% | 14.63% | |||||||
NOPAT | 70,975 | 96,351 | 60,843 | |||||||
Net income | 80,626 -8.08% | 87,714 47.94% | 59,289 13.33% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | 100,000 | 60,000 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 8,307 | 9,520 | 2,589 | |||||||
Net debt | (102,535) | (161,163) | (208,506) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 102,673 | 89,231 | 36,214 | |||||||
CAPEX | (158,975) | (136,384) | (79,085) | |||||||
Cash from investing activities | (150,111) | (101,499) | (79,007) | |||||||
Cash from financing activities | 39,076 | 60,000 | ||||||||
FCF | (73,323) | (41,504) | (38,850) | |||||||
Balance | ||||||||||
Cash | 200,602 | 219,235 | 206,838 | |||||||
Long term investments | 1,933 | 1,928 | 1,668 | |||||||
Excess cash | 186,222 | 205,190 | 195,909 | |||||||
Stockholders' equity | 889,471 | 806,762 | 718,805 | |||||||
Invested Capital | 807,842 | 662,234 | 520,194 | |||||||
ROIC | 9.66% | 16.30% | 12.97% | |||||||
ROCE | 8.10% | 11.48% | 9.50% | |||||||
EV | ||||||||||
Common stock shares outstanding | 13,816 | 13,812 | 13,809 | |||||||
Price | 238.00 -8.46% | 260.00 2.36% | 254.00 38.80% | |||||||
Market cap | 3,288,127 -8.44% | 3,591,087 2.38% | 3,507,496 52.05% | |||||||
EV | 3,185,592 | 3,429,924 | 3,298,990 | |||||||
EBITDA | 103,458 | 123,424 | 98,241 | |||||||
EV/EBITDA | 30.79 | 27.79 | 33.58 | |||||||
Interest | 943 | 2,119 | 391 | |||||||
Interest/NOPBT | 1.14% | 2.06% | 0.55% |